By Danielle Kaye and Alexander Marrow NEW YORK, Oct 22 (Reuters) - Lorraine Scott has spent at least $300 to tailor her pants ...

The Menopause Society noted that middle-aged women commonly experience weight gain resulting from menopause, and have turned to GLP-1 drugs for help. About 1 in 5 women 50 to 64 are or have used a GLP ...

Novo released new evidence that its experimental CagriSema injection can improve upon the weight loss with its blockbuster ...

Having hormone therapy at the same time as taking semaglutide was associated with greater weight loss at menopause in a new study.

Popular diabetes and weight loss drugs such as Ozempic and Wegovy have been linked to a slightly increased risk of a rare ...

Around half a million Australians use GLP-1 medications for diabetes—and when you add people who use them for obesity and ...

The FDA recall is applicable to 64 prescribed 2mL prescription-only vials of Tirzepatide/Niacinamide compounded by Houston RX ...

Ram Kapoor suggested people to take Mounjaro or Ozempic if suggested by doctors but no drug can replace workouts ...

South African regulators have won an important court battle against a pharmacy making its own versions of popular weight-loss ...

"Ozempic feet" is an informal term describing heel pain and foot discomfort caused by the rapid loss of protective subcutaneous fat padding in the feet during GLP-1 weight loss therapy. Rapid body fat ...

Learn how rapid weight loss and Ozempic mouth can cause facial volume loss, aging signs, and costly cosmetic fixes.